Why Current Parkinson’s Trials Are Falling Short
Lather, rinse, repeat. Three researchers argue that traditional double-blind trials have followed the same cycle for decades, testing one drug at a time, failing to slow…
Tag: biomarkers
Understanding Parkinson’s Disease Through the Lens of Aging – Part 2
The role of aging in Parkinson’s disease continues to receive renewed attention from some of the field’s most prominent researchers and clinicians. More of them…